Skip to main content
OpenTrials

Clinical trial condition

CRC

Explore clinical trials studying CRC. Study availability and eligibility vary by location and protocol.

41 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

CRC trial results

Active, not recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

NCT06106308

Conditions
CRC, Colonic Diseases, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

NCT05736731

Conditions
Bronchial Neoplasms, CRC, Cancer, +38 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

NCT01394939

Conditions
CRC, Colonic Diseases, Colonic Neoplasms, +17 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Billings Clinic Cancer Center Billings, Montana, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

NCT05668585

Conditions
ATC, CRC, Melanoma, +13 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details

Related conditions